India 
Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products.
IIL operates one of the largest plants in the world for veterinary vaccines. IIL has adequate infrastructure and cold chain distribution capability to reach out to various parts of India and world market. This flexibility in logistics has ensured many products of IIL occupy top slots in the market.
IIL is a major player in the human vaccine market in India, focusing on the pediatric and rabies vaccine segments. IIL is also a major supplier of pediatric vaccines to India’s large Universal Immunization Programme.
Brief History of IIL
Indian Immunologicals was established by the National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making vaccines available to farmers at an affordable price. The unit was corporatized as Indian Immunologicals Limited in the year 1999.
IIL started manufacturing human vaccines in 1998 on a specific request by the Government of India. IIL is the second company in the world and first in India to launch purified vero cell rabies vaccine (PVRV) and markets it under the brand – Abhayrab. This led to the discontinuation of use of older and unsafe sheep brain derived vaccine (also termed Nerve Tissue Vaccine – NTV) in the country.
IIL not only provides products and services to enhance the quality of livestock in the country, but also utilizes its technological capabilities for the benefit of the people
IIL operates one of the largest plants in the world for veterinary vaccines. IIL has adequate infrastructure and cold chain distribution capability to reach out to various parts of India and world market. This flexibility in logistics has ensured many products of IIL occupy top slots in the market.
IIL is a major player in the human vaccine market in India, focusing on the pediatric and rabies vaccine segments. IIL is also a major supplier of pediatric vaccines to India’s large Universal Immunization Programme.
Brief History of IIL
Indian Immunologicals was established by the National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making vaccines available to farmers at an affordable price. The unit was corporatized as Indian Immunologicals Limited in the year 1999.
IIL started manufacturing human vaccines in 1998 on a specific request by the Government of India. IIL is the second company in the world and first in India to launch purified vero cell rabies vaccine (PVRV) and markets it under the brand – Abhayrab. This led to the discontinuation of use of older and unsafe sheep brain derived vaccine (also termed Nerve Tissue Vaccine – NTV) in the country.
IIL not only provides products and services to enhance the quality of livestock in the country, but also utilizes its technological capabilities for the benefit of the people